These findings are consistent with a previous study demonstrating that non-canonical Wnt5a enhances migration of glioma cells by regulating the expression of matrix metalloproteinases (MMPs) involved in extracellular matrix (ECM) degradation [66]. The gene discussed is WNT5A; the disease is glioma.